• Profile
Close

Prostate cancer research examines radiation protocol for the whole pelvis

Newswise May 22, 2019

Treating an aggressive disease is always challenging, but improving the way therapies are applied can benefit patients by giving them a better outcome.

In a new study published in European Urology, UCLA researchers and colleagues from 10 other institutions examined the protocol for treating aggressive prostate cancer. With aggressive forms of this disease, it is often unclear if radiation therapy should be applied to the prostate alone or to the whole pelvis. The reason a low-dose of radiation may be applied to the whole pelvis is that pelvic lymph nodes may have microscopic cancer cells within them.

Previous tests have proven that a high dose of radiation is effective in treating prostate cancer. This new study set out to learn if treating men with a high dose of radiation for their prostate, along with a lower dose of radiation for their pelvic lymph nodes, would improve their outcomes.

“We undertook this study because several randomized trials have failed to show any benefit to prophylactically treating the whole pelvis region with radiation along with treating the prostate,” said Dr. Amar Kishan, a member of the UCLA Jonsson Comprehensive Cancer Center. “However, these trials have been limited by delivering substandard doses of radiation to the prostate. This raises the question of whether treating the pelvic nodes in conjunction with high-dose radiation to the prostate would be helpful.”

The study assessed 1,170 patients who were treated between 2000 and 2013 for an aggressive form of prostate cancer. Using a statistical model, the UCLA researchers compared the outcomes for men who were treated with radiation for their prostate alone vs men who received similar high-dose treatment for their prostate in conjunction with radiation for their whole pelvis.

The study results showed that patient outcomes improved when they received a high dose of radiation therapy for their prostate along with radiation for their whole pelvic region. The UCLA researchers, however, also noted that a randomized trial is required to further prove their conclusions.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay